EverSource Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
1,786
+1,441
| +418% | +$181K | 0.01% | 810 |
|
|
2025
Q1 | $38.2K | Sell |
345
-121
| -26% | -$13.4K | ﹤0.01% | 1371 |
|
|
2024
Q4 | $63.6K | Buy |
466
+241
| +107% | +$32.9K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $25.9K | Buy |
225
+49
| +28% | +$5.65K | ﹤0.01% | 1354 |
|
|
2024
Q2 | $24.9K | Buy |
176
+32
| +22% | +$4.53K | ﹤0.01% | 1397 |
|
|
2024
Q1 | $19.8K | Buy |
144
+22
| +18% | +$3.03K | ﹤0.01% | 1365 |
|
|
2023
Q4 | $16.1K | Buy |
122
+1
| +0.8% | +$132 | ﹤0.01% | 1340 |
|
|
2023
Q3 | $13.6K | Buy |
121
+37
| +44% | +$4.16K | ﹤0.01% | 1278 |
|
|
2023
Q2 | $7.92K | Buy |
84
+79
| +1,580% | +$7.45K | ﹤0.01% | 1553 |
|
|
2023
Q1 | $506 | Buy |
+5
| New | +$506 | ﹤0.01% | 2222 |
|